Expertise in
2
conditions

Petros K. Tsantoulis

Geneve, GE, CH 
Expertise in
2
conditions
Geneve, GE, CH 

Overview

Petros Tsantoulis practices practicing medicine in Geneve, Switzerland.

Mr. Tsantoulis is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Squamous Cell Carcinoma of the Anal Canal (SCAC), Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Bladder Cancer, and Cystectomy.

He is actively involved in clinical research, co-authoring 67 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Geneve, GE, Switzerland
Other Locations
Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Intravesical Recombinant BCG (Bacillus Calmette Guérin) Followed by Perioperative Chemo-immunotherapy for Patients With Muscle-invasive Bladder Cancer (MIBC). A Multicenter, Single-arm Phase II Trial
Intravesical Recombinant BCG (Bacillus Calmette Guérin) Followed by Perioperative Chemo-immunotherapy for Patients With Muscle-invasive Bladder Cancer (MIBC). A Multicenter, Single-arm Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drugs: Recombinant intravesical BCG, Atezolizumab, Cisplatin, Gemcitabine
Study Phase: Phase 2

67 Total Publications

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026

Frequently Asked Questions about Petros K. Tsantoulis

Is Petros K. Tsantoulis a top-rated expert for Squamous Cell Carcinoma of the Anal Canal (SCAC)?

MediFind is an objective health platform that identifies experts based on real-world data. Petros K. Tsantoulis is classified as an Advanced expert for Squamous Cell Carcinoma of the Anal Canal (SCAC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Petros K. Tsantoulis participate in research or clinical trials?

Yes. Petros K. Tsantoulis has published 67 articles and abstracts on conditions like Squamous Cell Carcinoma of the Anal Canal (SCAC). You can view a list of Petros K. Tsantoulis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tsantoulis's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile